Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ACAD
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

ACADIA Pharmaceuticals Inc. (ACAD) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ACAD trades at $27.29, down 0.91% on the day, with a bearish technical signal despite strong fundamental performance. The company reported impressive Q2 2026 earnings of $0.18 per share, beating expectations by 164%, and raised full-year guidance. Revenue growth has been robust, climbing from $517M in 2022 to $1.07B in 2025, with net income turning positive in 2024 and reaching $391M in 2025. The stock faces technical headwinds with bearish moving averages but maintains strong analyst support with 70% buy ratings and a $33.83 consensus target representing 24% upside potential.
The outlook remains positive based on fundamental strength, with European approval for DAYBU expanding market reach and strong product sales driving earnings beats. Key risks include negative cash flow from aggressive investing activities and competitive pressures in the biopharmaceutical space. The current valuation at 12.31 P/E appears reasonable given the company's profitability trajectory and growth prospects, though technical weakness suggests potential near-term consolidation before resuming upward momentum.
Read full analysis

Key Stats

  • Market Cap
    $4.73B
  • Volume
    1,276,391
  • Sector
    Health
  • 52W High
    $30.57
  • 52W Low
    $20.06
  • Typical Hold Time
    76 Days
  • Enterprise Value
    $3.85B
  • Div Yield
    -
  • Trading Activity
    93% Sell | 7% Buy
$27.27
52W Low: $20.06
13 Oct 2025
52W High: $30.57
25 Aug 2026

Track ACADIA Pharmaceuticals Inc. (ACAD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ACADIA Pharmaceuticals Inc. has traded between a low of $20.06 and a high of $30.57, highlighting its annual price range. Buy and sell ACADIA Pharmaceuticals Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Most Recent News

Content is generated by Aura AI

La-Z-Boy director Janet Kerr sells 3,653 shares for $116,000.

Janet Kerr, a director at La-Z-Boy, has sold 3,653 shares of the company, generating $116,000 from the transaction. This sale could indicate a personal financial decision or portfolio adjustment, but it may also attract investor attention regarding i...

Market News
1 hour ago
Jack Delaney
Neutral
La-Z-Boy director Janet Kerr sells 3,653 shares for $116,000.

AI and crypto stocks surge as TJGC plans AI expansion and FWDI updates SkyAI acquisition offer

Shares of TJGC Group Limited jumped nearly 54% after announcing plans to expand into AI hardware, led by new leadership in electronics manufacturing. Forward Industries rose 24% following an updated acquisition proposal for SkyAI, offering a 50% prem...

Market News
2 hours ago
Alex Lavoie
Bullish
news icon
AI and crypto stocks surge as TJGC plans AI expansion and FWDI updates SkyAI acquisition offer

Fluence Energy faces SEC probe and cuts 2026 EBITDA loss forecast to $200M, triggering investor lawsuit.

Fluence Energy disclosed an ongoing SEC investigation into its revenue recognition and internal controls, alongside a drastic revision of its fiscal 2026 adjusted EBITDA outlook from a $10 million loss to a $200 million loss. This sharp downgrade cau...

Market News
4 hours ago
PRNewsWire
Bearish
news icon
Fluence Energy faces SEC probe and cuts 2026 EBITDA loss forecast to $200M, triggering investor lawsuit.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $4.73B
  • Volume
    1,276,391
  • Sector
    Health
  • 52W High
    $30.57
  • 52W Low
    $20.06
  • Typical Hold Time
    76 Days
  • Enterprise Value
    $3.85B
  • Div Yield
    -
  • Trading Activity
    93% Sell | 7% Buy
$27.27
52W Low: $20.06
13 Oct 2025
52W High: $30.57
25 Aug 2026

Track ACADIA Pharmaceuticals Inc. (ACAD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ACADIA Pharmaceuticals Inc. has traded between a low of $20.06 and a high of $30.57, highlighting its annual price range. Buy and sell ACADIA Pharmaceuticals Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!